Azelis said the transaction enhances its lateral value chain by diversifying and expanding its presence in France and EMEA, as well as providing Azelis in EMEA with a foothold in the growing noncyclical markets of flavors and fragrances, synergistic opportunities in animal nutrition, and expanding its offering in nutraceuticals.
Quimdis was founded in 1988 by Jean-François Quarré, Michel Manalt and Claire Couratier, originally focusing on essential oils and active ingredients. It now specializes in ingredients distribution and formulation development, in the French market and with sales to more than 45 countries.
Quimdis, which is headquartered in Paris and has sales close to €100m, has 78 employees, more than 1,000 customers and around 400 suppliers.
Azelis said the acquisition strengthens its offering to fast-growing and attractive markets, and enhances the position of Azelis France in the life sciences sector. Azelis said it is now positioned to develop, structure and implement a global strategy for the flavor & fragrance market with the aim of becoming a market leader.
Benoit Fritz, managing director of Azelis France, said, “Azelis will leverage Quimdis’ expertise to complement our lateral value chain with reliable, natural and value-added products like essential oils and active ingredients. We will further benefit from their strong presence across EMEA, expertise and product portfolio in attractive target market segments and geographies.”